ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 13.2K shares valued at $162.00. A 1.08% stake in Pasithea Therapeutics Corp. is owned by the company. ARMISTICE CAPITAL, LLC owns 50K shares valued at $615.00, which translates its holding of 4.08% of the stake in the company.
Among the KTTAW insiders holding of N/A of the stake in company, STEINMAN LAWRENCE, director, holds the largest shares of 1.33M. DELANEY DAVID, director, is the second largest KTTAW insider with ownership of 227.52K shares. , , stands third with possession of - shares of that stake.